Ab. Federici et al., ORTHOTOPIC LIVER-TRANSPLANTATION IN A PATIENT WITH SEVERE HEMOPHILIA-A - A LIFESAVING TREATMENT FOR THE FIRST ITALIAN CASE, International journal of clinical & laboratory research, 25(1), 1995, pp. 44-46
Clinical cure of hemophilia A by orthotopic liver transplantation has
been reported in 11 cases. We describe the first successful Italian ca
se. A 27-year-old man had cirrhosis caused by previous infections with
the hepatitis B, C and D viruses following life-long treatment with f
actor VIII concentrates made from large plasma pools. He was, however,
seronegative for the human immunodeficiency virus. In the year before
transplantation, life-threatening gastrointestinal bleeding due to se
vere esophageal varices required a large transfusion regimen (on avera
ge, 13 bags of red cell concentrates and 35,000 U of factor VIII/week)
. To perform orthotopic liver transplantation 8,000 U of factor VIII w
ere given during surgery together with 10 bags of red cells and 11 of
fresh-frozen plasma. Intraoperative bleeding was not different from th
at of non-hemophilic patients undergoing orthotopic liver transplantat
ion. No additional factor VIII was used after transplantation and fact
or VIII levels in plasma were always above 50 U/dl, reaching the highe
st value of 184 U/dl on day 4 post transplantation. He was discharged
from hospital 10 weeks after transplantation with factor VIII levels o
f 68 U/dl. All virological markers are currently negative, except anti
-hepatitis C virus antibodies. In this patient orthotopic liver transp
lantation was a life-saving treatment for end-stage cirrhosis and a cu
re for hemophilia A.